Structure

InChI Key VXBAJLGYBMTJCY-NSCUHMNNSA-N
Smile CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1
InChI
InChI=1S/C23H24N4O/c1-27-13-3-2-4-14-28-21-10-6-8-19(16-21)22-11-12-24-23(26-22)25-20-9-5-7-18(15-20)17-27/h2-3,5-12,15-16H,4,13-14,17H2,1H3,(H,24,25,26)/b3-2+

Physicochemical Descriptors

Property Name Value
Molecular Formula C23H24N4O
Molecular Weight 372.47
AlogP 4.66
Hydrogen Bond Acceptor 5.0
Hydrogen Bond Donor 1.0
Number of Rotational Bond 0.0
Polar Surface Area 50.28
Molecular species NEUTRAL
Aromatic Rings 3.0
Heavy Atoms 28.0

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Cyclin-dependent kinase 1 inhibitor PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Leukemia, Lymphocytic, Chronic, B-Cell 1 D015451 ClinicalTrials
Glioblastoma 1 D005909 ClinicalTrials
Rectal Neoplasms 1 D012004 ClinicalTrials
Carcinoma, Hepatocellular 1 D006528 ClinicalTrials
Gliosarcoma 1 D018316 ClinicalTrials

Related Entries

Scaffolds

Cross References

Resources Reference
ChEMBL CHEMBL1944698
FDA SRS 40D08182TT
Guide to Pharmacology 9095
PubChem 16739650
SureChEMBL SCHEMBL823947
ZINC ZINC000068251500